DYNAGLIPT L (Linagliptin (5mg))

Dynaglipt L Tablet is a medication indicated for the management of type 2 diabetes mellitus. It is intended to be used in conjunction with a balanced diet and regular physical activity to effectively regulate blood glucose levels. Effective blood sugar control is crucial for minimizing the risk of severe diabetes-related complications, such as damage to the kidneys and loss of vision. This medication is typically prescribed when lifestyle changes along with other treatments are insufficient to manage blood sugar effectively. Your healthcare provider may recommend this medication alone or alongside additional diabetes treatments. It can be administered with or without food, and the appropriate dosage will be determined by your healthcare professional based on your individual condition and blood glucose readings. It is essential to adhere strictly to your doctor’s instructions regarding usage. Discontinuation of the medication should only occur under medical advice. Maintaining the lifestyle changes recommended by your healthcare provider is vital while using this medication, as they significantly influence diabetes management. The most frequently reported side effect associated with this medication is hypoglycemia, which is a condition characterized by low blood sugar levels. Recognizing hypoglycemia symptoms, such as dizziness, sweating, lightheadedness, and fainting, is important, and individuals are encouraged to carry sugar or glucose tablets to alleviate these symptoms when necessary. Additionally, some users may experience nasopharyngitis. If side effects persist or cause concern, it is advised to contact your healthcare provider for guidance.